Coffee consumption reduces side-effects in people on hepatitis C treatment
Unexplained liver enzyme increases in patients with HIV could be due to hepatitis E virus: screening recommended
Co-infection with hepatitis delta increases risk of death for patients with HIV and chronic hepatitis B
Some rapid hepatitis C tests have high false-negative rate in people with HIV
Boceprevir response and resistance differs according to HCV genotype 1 subtype
Maraviroc improves liver fibrosis in HIV/hepatitis C co-infected patients
3TC has limited impact on HBV for hepatitis B / HIV-coinfected in South African trial
With special training, effective and safe hepatitis C therapy can be provided in primary care
